Chondrocytes

Chondrocytes are the only resident cell of healthy cartilage. Expanded under GMP conditions they are used to resurface focal cartilage defects and support joint function.

How Chondrocytes are used

The therapeutic value of Chondrocytes lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.

Conditions where Chondrocytes feature

Quality & safety

• GMP-certified preparation in the European Union
• Characterised, viability-tested cells from a certified bank
• Personalised dosing within a physician-led protocol
• Transparent pricing — €3,000–€8,000 per programme

Educational information. Chondrocytes protocols for several conditions remain investigational; outcomes vary by patient.